Tachosil (human fibrinogen/human thrombin) - Important Safety Information from Takeda UK Ltd. as approved by the HPRA

Notice type: 3rd Party Publications

Date: 04/02/2016

Problem Or Issue:
Important Safety Information communication from Takeda UK Ltd. on new recommendations to mitigate the risk of intestinal obstruction associated with TachoSil (human fibrinogen/human thrombin).

Important Safety Information - TachoSil (human fibrinogen, human thrombin)

Annex 1 - Revised SmPC

Annex 2 - Updated Instructions for Use

« Back